ArticleBritish journal of cancer2026
Association between effectiveness of treatment with curative intent and outcomes of first-line systemic therapy in metachronous metastatic gastroesophageal adenocarcinoma.
Article in British journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlmost half of the patients with gastroesophageal cancer treated with curative intent develop recurrence. It is unknown whether the effectiveness of curative treatment is associated with the outcomes of subsequent first-line systemic therapy.
methodsFrom the Netherlands Cancer Registry, we identified patients with metachronous metastatic gastroesophageal adenocarcinoma(mGEA) initially treated for nonmetastatic disease(2015-2017) with perioperative chemotherapy or neoadjuvant chemoradiotherapy, who later received first-line systemic therapy. Effectiveness of the treatment with curative intent was assessed by time-to-treatment-failure(TTF) and by pathological response. First-line systemic therapy outcomes were assessed by TTF and overall survival(OS). Associations were analysed using Kaplan-Meier curves and multivariable Cox models.
resultsPatients treated with perioperative chemotherapy (n = 81) and neoadjuvant chemoradiotherapy (n = 249) with a TTF longer than the median (19.6 and 14.9 months, respectively) had significantly longer first-line TTF(HR 1.94 95% CI: 1.18-3.19; HR 1.36, 95%CI: 1.04-1.78). This also translated into longer OS for neoadjuvant chemoradiotherapy (HR 1.35 95% CI 1.03-1.77). Pathological response was not associated with systemic therapy outcomes.
conclusionsA longer TTF of curative treatment was positively associated with improved first-line systemic therapy outcomes in patients with metachronous mGEA. When counselling patients, TTF of their curative treatment may be considered, whereas pathological response may not.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.